MRNA (Moderna) Technical Analysis

MRNA Technical Analysis leverages historical price and volume data to provide real-time indicator values and signals, including RSI, MACD, Bollinger Bands, and volume, to reflect market momentum, volatility ranges, and price-volume dynamics. It also integrates market sentiment metrics such as the VIX volatility index, Advance-Decline ratio (A/D ratio), and Put/Call options ratio for broader market context. Multi-timeframe views span from minute intervals to daily, weekly, and monthly charts, making it easy to track indicator behavior across periods. Key support and resistance levels are displayed alongside current prices, calculated via pivots, Fibonacci retracements, and historical extremes to offer an immediate overview of market structure.
MRNA
MRNA

Moderna

$73.52+5.76%
Today's High$73.85
Today's Low$68.92
Today's Open$69.41
Yesterday's Close$69.51

MRNA (Moderna) Technical Analysis Overview

AI CreationAs of June 30, 2026, Moderna (MRNA) is showing bullish upward movement. The MACD Level at 5.0011 confirms a Buy signal with golden cross formation, indicating sustained positive momentum, while RSI(14) at 74.7665 places the stock in overbought territory (>70), suggesting aggressive bullish sentiment with potential pullback risk. The moving average system displays strong bullish alignment with EMA10 at 63.0623 trading above EMA20 at 58.4488, and both well above SMA200 at 40.6012, establishing a coherent bullish structure across timeframes with 14 Buy signals versus 0 Sell on the daily timeframe. The **MRNA technical analysis** reveals a price structure in an extended rally phase, though the overbought RSI reading warrants monitoring for near-term consolidation or pullback.

Oscillators

Strong Sell
Strong Buy
Neutral
1
Sell
8
Neutral
2
Buy

Summary

Strong Sell
Strong Buy
Strong Buy
1
Sell
9
Neutral
16
Buy

Moving Averages

Strong Sell
Strong Buy
Strong Buy
0
Sell
1
Neutral
14
Buy

MRNA (Moderna) Live Candlestick Chart

MRNA (Moderna) Multi-Timeframe Technical Rating

Summary1H4H1D1W
Moving Averages (15)131140140131
Oscillators (11)NeutralNeutralNeutralNeutral
RSI (14)69.475.876.574.2
MACD (12,26)Golden CrossGolden CrossGolden CrossGolden Cross

MRNA (Moderna) Technical Indicator Interpretation

Based on 1-day closing price series

Oscillators

NameValueOperation
RSI(14)
76.51Neutral
Stochastic %K (14, 3, 3)
95.3147Neutral
Commodity Channel Index (CCI) (20)
136.0759Sell
Average Directional Index (ADX) (14)
31.1658Neutral
Awesome Oscillator (AO)
13.9262Neutral
Momentum Indicator (10)
18.075Buy
MACD Level (12, 26)
5.4749Buy
Stochastic RSI Fast (3, 3, 14, 14)
97.0857Neutral
Williams Percent Range (%R) (14)
-1.4685Neutral
Bull Bear Power (BBP)
16.9562Neutral
Ultimate Oscillator (UO) (7, 14, 28)
61.1892Neutral

Moving Averages

NameValueOperation
EMA (10)
64.757Buy
SMA (10)
64.675Buy
EMA (20)
59.7648Buy
SMA (20)
57.162Buy
EMA (30)
57.1187Buy
SMA (30)
53.744Buy
EMA (50)
54.3828Buy
SMA (50)
52.1608Buy
EMA (100)
50.2246Buy
SMA (100)
51.378Buy
EMA (200)
45.3901Buy
SMA (200)
40.8444Buy
Ichimoku Kinko Hyo Base Line (9, 26, 52, 26)
58.89Neutral
Volume-Weighted Moving Average (VWMA) (20)
59.1976Buy
Hull Moving Average (HMA) (9)
72.8026Buy

MRNA (Moderna) Pivot Points

Based on 1-day timeframe

PriceClassicFibonacciCamarillaWoodieDM
R3121.163391.783378.1095114.11-
R291.783380.560275.416393.695-
R180.906773.626572.723284.7386.345
Pivot P62.403362.403362.403364.31565.1225
S151.526751.180267.336855.3556.965
S233.023344.246564.643734.935-
S33.643333.023361.950525.97-

MRNA (Moderna) Market Sentiment Index

Analyst Rating44.25
Options Put/Call Ratio+34.39%
Implied Volatility (IV)71.5093

MRNA (Moderna) Deep Technical Analysis

As of June 30, 2026, Moderna (MRNA) is exhibiting a bullish technical structure with price action currently at 70.26, up 1.35% on the session, with the day high reaching 73.19 and low at 69.18. The MACD Level at 5.0011 confirms a Buy signal with golden cross formation, indicating sustained upside momentum; **MRNA technical analysis** shows RSI(14) at 74.7665 in overbought territory (>70), suggesting aggressive bullish sentiment and potential exhaustion risk in the near term. The Momentum(10) reading of 19.235 with Sell signal presents a divergence from the bullish price structure, warranting attention to potential momentum exhaustion. The Average Directional Index (14) at 29.3228 with a Neutral signal indicates moderately strong trend strength, suggesting the market structure is well-defined and directionally committed. The Commodity Channel Index at 148.0986 with a Neutral signal indicates the market is not yet in extreme overextension, while the Awesome Oscillator at 12.5064 and Bull Bear Power at 20.471 both remain neutral, reflecting a balance between buying and selling pressure without exhaustion signals. These supporting oscillators suggest the rally has developed room but warrant monitoring for momentum divergences. The moving average system demonstrates strong bullish alignment with EMA10 at 63.0623 trading above EMA20 at 58.4488, confirming short-term upside momentum and directional strength. EMA50 at 53.6559 provides intermediate-term support, while SMA200 at 40.6012 anchors the longer-term uptrend, with price well above this key level. The MRNA market analysis benefits from all major moving averages in Buy configuration (14 Buy signals on the daily timeframe versus 0 Sell), establishing a coherent bullish structure across timeframes. The Hull Moving Average at 69.7718 with Buy signal and Ichimoku Base Line at 58.59 with Neutral signal both support the upside bias without contradicting the primary trend. In terms of key levels, the Fibonacci retracement framework provides R1 at 56.1523, R2 at 59.8811, and R3 at 65.9167 as reference targets, while S1 at 44.0811 and S2 at 40.3523 define support zones. Current price at 70.26 has moved above R3 at 65.9167, establishing new resistance territory. The recent trading range (low 69.18, high 73.19) establishes immediate support near 69.18 and resistance near 73.19, providing tactical reference points for near-term positioning. The MRNA price forecast remains constructive as long as price holds above EMA20 at 58.4488, though the overbought RSI suggests caution on new long entries. On the market breadth front, the analyst rating at 44.25 reflects moderately positive sentiment among market professionals, supporting the bullish technical structure. The option Put/Call ratio at 33.22 suggests hedging activity with a tilt toward call positioning, indicating market participants are constructive on further upside. The implied volatility reading at 73.1616 indicates elevated price uncertainty, reflecting the sharp rally. The overall market backdrop combines extended bullish structural signals with constructive derivatives positioning, suggesting the MRNA price prediction remains tilted higher but the overbought condition warrants monitoring for consolidation or pullback risk.

FAQ

What is the current technical rating for MRNA?

x
On the 4H timeframe, the aggregate technical rating for MRNA is Strong Buy. This rating is dynamically aggregated from moving averages and momentum oscillators to reflect the prevailing trend direction and price velocity.

Where are the key support and resistance levels for MRNA?

x

What are the current RSI and MACD signals for MRNA?

x

How often is the MRNA technical analysis data updated?

x

Continue Exploring MRNA (Moderna)

Risk Warning:

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Warning.

Disclaimer:

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.